Acton

Acton medical device firm Insulet has acquired $25 million of diabetes pump technology from California-based Bigfoot Biomedical, nearly doubling Insulet’s intellectual property.

The landscape for women’s business leadership at the highest level in Central Mass. has taken a hit, but for women professionals in the region, it is yet another motivator to empower one another in traditional and non-traditional ways.

Neil Gordon, the CEO of the Discovery Museum in Acton, will retire on Dec. 31 after 14 years of leading the organization.

Acton medical device manufacturer Insulet Corp. issued a voluntary medical device correction on its Omnipod DASH Personal Diabetes Manager on Oct. 17.

Will a big bank like Chase put Central Massachusetts-headquartered banks at a disadvantage? Industry leaders here don’t think so.

When Shacey Petrovic stepped down as CEO of Acton medical-device company Insulet in May for personal reasons, she left Central Massachusetts without a single public company headquartered here, traded on NASDAQ or New York Stock Exchange, with a woman as CEO.

The U.S. Food and Drug Administration has cleared an insulin delivery system from Acton medical device firm Insulet Corp. for children two years and older with type 1 diabetes.

Led by Worcester manufacturing tech firm Solvus Global, 19 Central Massachusetts firms made the 2022 Inc. 5000, a national list of the fastest growing companies from the New York City magazine.

Chase bank will open its first Worcester bank branch in September. It is part of a plan to double the bank's presence in Massachusetts by 2025.

Chuck Alpuche, executive vice president and COO of Acton medical device manufacturer Insulet Corp. has been appointed to the board of Athol manufacturing firm The L.S. Starrett Co. according to a Monday press release.